Accordingly, several germline variants that are able to impair BRCA1/2 functions have been identified so far and have been related to an increased lifetime risk of developing cancers, particularly breast and ovarian cancers, within the framework of the so-called hereditary breast and ovarian cancer syndrome (HBOC) [2,3,6,7]. Here, BRCA1 is linked to ovarian carcinoma.